2019年新冠肺炎患者的门诊remdesivir治疗计划:患者的看法,过程和经济影响
Supavit Chesdachai1, Christina G Rivera2, Jordan K Rosedahl3
1Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.
Healthcare (Amsterdam, Netherlands)
|August 14, 2024
概括
作为门诊患者继续治疗COVID-19的remdesivir治疗改善了患者的满意度,并大大降低了医疗保健成本. 这种方法还为其他急症护理需求释放了医院床位.
科学领域:
- 传染性疾病 传染性疾病
- 卫生经济学 卫生经济学
- 以患者为中心的护理
背景情况:
- 雷梅西维尔是FDA批准的抗病毒药物,用于住院患者的严重COVID-19.
- 早期的临床改善使得一些患者在完成标准的5天雷梅西维尔疗程之前就能出院.
- 之前的研究表明,患者继续在门诊治疗雷梅西维尔的28天后的结果有所改善.
研究的目的:
- 评估患者在门诊环境中继续治疗雷梅西维尔的观点.
- 评估将COVID-19患者转换为门诊治疗的经济影响.
- 确定对医院资源利用率的影响.
主要方法:
- 在梅奥诊所 (11/2020-11/2021) 继续治疗雷梅西维尔门诊的住院COVID-19患者的调查.
- 住院和门诊治疗群体之间的医疗保健费用比较.
- 分析患者的满意度和对护理质量的感知.
主要成果:
- 93/470 (19.8%) 符合条件的患者作出反应;响应者年龄较大.
- 大多数受访者 (70.5%) 的症状已经消失;11.4%的人报告了长期的COVID-19症状.
- 报告的门诊输液诊所护理的高患者满意度 (82.3%的质量,76.0%的整体经验).
- 预计成本:每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者) 每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01),每名患者 (p < .01)
- 估计有1,077个医院病床日被节省.
结论:
- 门诊的remdesivir计划有助于提前解雇患者,并受到人们的好评.
- 通过这种门诊转型实现了显著的成本节约.
- 该计划提高了医院对关键服务的资源可用性.
相关概念视频
Discharge Summary Forms
749
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
749
Pneumonia IV: Management
313
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
Restorative Care
1.9K
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
1.9K


